What is the price target for VMD stock?
6 analysts have analysed VMD.CA and the average price target is 19.25 CAD. This implies a price increase of 84.23% is expected in the next year compared to the current price of 10.45.
Viemed Healthcare Inc (VMD.CA) Forecast, Price Target & Analyst Ratings
TSX:VMD • CA92663R1055
Current stock price
10.45 CAD
+0.29 (+2.85%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Viemed Healthcare Inc (VMD.CA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- $0.09
- Revenue Estimate
- 50.955M
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$19.25
Upside
+ 84.23%
From current price of CA$10.45 to mean target of CA$19.25, Based on 6 analyst forecasts
Low
CA$18.18
Median
CA$19.25
High
CA$20.74
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for VMD.CA. The average price target is 19.25 CAD. This implies a price increase of 84.23% is expected in the next year compared to the current price of 10.45.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
VMD.CA was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VMD.CA.
In the previous month the buy percentage consensus was at a similar level.
VMD.CA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- $0.09
- Revenue Estimate
- 50.955M
- Revenue Q2Q
- 35.84%
- EPS Q2Q
- 51.50%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
96,920.20%
EPS (1 Month)
0.00%
EPS (3 Months)
-18.18%
Next Earnings Summary
The next earnings revenue estimate has been revised upward by 96920.2% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 131.3M 63.51% | 117.1M -10.81% | 138.8M 18.53% | 184.53M 32.95% | 222.15M 20.39% | 251.49M 13.21% | |
| EBITDA YoY % growth | 34.08M 119.87% | 23.31M -31.60% | 24.23M 3.95% | 42.824M 76.74% | 52.672M 23.00% | 62.216M 18.12% | |
| EBIT YoY % growth | 24.5M 169.23% | 12M -51.02% | 8.6M -28.33% | 14.645M 70.29% | 22.018M 50.34% | N/A | |
| Operating Margin | 18.66% | 10.25% | 6.20% | 7.94% | 9.91% | N/A | |
| EPS YoY % growth | 0.78 239.13% | 0.22 -71.79% | 0.15 -31.82% | 0.26 75.07% | 0.41 55.77% | 0.56 35.80% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 51.50% | 0.08 102.00% | 0.10 68.33% | 0.10 44.29% | 0.13 44.44% |
| Revenue Q2Q % growth | 50.955M 35.84% | 52.419M 32.51% | 54.439M 25.70% | 56.56M 14.49% | 58.782M 15.36% |
| EBITDA Q2Q % growth | 12.423M -35.77% | 11.413M 71.11% | 12.726M -2.03% | 13.029M -36.23% | 14.241M 14.63% |
| EBIT Q2Q % growth | 5.555M 49.73% | 4.04M 111.52% | 5.353M 77.25% | 5.555M 23.72% | 6.868M 23.64% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
54.71%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
21.44%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
76.08%
EBIT Next 5 Year
N/A
Viemed Healthcare Inc / VMD.CA Forecast FAQ
Can you provide the consensus estimates for Viemed Healthcare Inc next earnings?
The consensus EPS estimate for the next earnings of Viemed Healthcare Inc (VMD.CA) is 0.09 CAD and the consensus revenue estimate is 50.95M CAD.
What is the consensus rating for VMD stock?
The consensus rating for Viemed Healthcare Inc (VMD.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.